Xenomorph
  • Solutions
  • Technology
  • Customers
  • Resources
  • News
  • About Us
  • Request a Demo
  • Search
  • Menu Menu
  • Twitter
  • LinkedIn

News

CDS Asymmetry not for Soros

Interesting views in an article by George Soros in today’s FT. Whilst dealing with the current crisis and the difficulty of its remedy in general, Soros spends a little time on short selling and continuing his warnings about CDS contracts and other OTC derivatives.

In contrast with short selling, where upside is limited but downside risk is not (and increases as more losses are incurred), he explains that effectively shorting a stock through buying a CDS contract has the reversed asymmetry of risk. On buying a CDS, the downside risk is limited (to the premium), whilst the upside risk is unlimited (not sure I agree, maybe practically unlimited is better used). Using this asymmetry in risk profile, he joins John Dizard in railing against what he perceives as the instability caused by the CDS market and “toxic” OTC derivatives.

He suggests that shorting is an acceptable market practice (I guess he would, have made a lot of money from shorting) but that some market constraints might be sensible in re-introducing rules such as no naked short-selling and allowing shorting only on an up-tick.

Most controversially rather than just accepting the common view that CDS contracts need to be traded and cleared within regulated markets, he advocates a more stringent process where OTC derivatives would need to go through a very formal and regulated “issuance” process similar to that undertaken when issuing a new stock on an exchange. Given history and the market’s economic need for innovation I struggle to see this happening on a large scale, even in light of the crisis – but I guess nothing is to be ruled out in current times.

Share this entry
  • Share on Twitter
  • Share on LinkedIn
  • Share by Mail
https://www.xenomorph.com/wp-content/uploads/2019/07/logo-xeno.png 0 0 Brian Sentance https://www.xenomorph.com/wp-content/uploads/2019/07/logo-xeno.png Brian Sentance2009-01-29 11:07:192020-02-11 10:36:06CDS Asymmetry not for Soros

Categories

  • Blog Post
  • Events
  • Press Release

Archives

About Xenomorph

Xenomorph provides trusted data management solutions to many of the world’s leading financial institutions.

With more than two decades’ experience managing large volumes of complex data and analytics we can quickly configure a solution for your requirements.

Xenomorph London

4th Floor
10 Lloyd’s Avenue
London EC3N 3AJ
UK

+44 (0)20 7614 8600

info@xenomorph.com

map

Xenomorph New York

45 Rockefeller Plaza, FL 20
New York
NY 10111
USA

+1-212-401-7894

info@xenomorph.com

map


Xenomorph Boston

53 State Street
Suite 500
Boston, MA 02109
USA

+1-617-465-2050

info@xenomorph.com

map

© Xenomorph Software Ltd 2022 - Privacy policy | Anti-Bribery Policy
Scroll to top
This website uses cookies to improve your experience. If you continue to use the site we will assume your consent. ACCEPTRead More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT